About Us
By operating under continuous blood flow conditions, the Cellix platform simulates the human environment providing researchers with powerful data far beyond that available via static conditions of the petri dish before advancing to costly animal trials. By using our solution, false leads can be eliminated earlier in the process, increasing the success rate of clinical trials and giving you the competitive edge.
Our solution is unique and contains everything a researcher requires to execute continuous flow cell based assays and make informed decisions. The only fully integrated end-to-end Microfluidics system on the market, the Cellix solution includes the platform, biochips and cell analysis software. During the consultation phase, our team will run a demonstration and ensure your team are fully trained to get the most from the platform within your specialist disease area. Cellix provides customised solutions for all its clients depending on what is needed.
Over a third of the top ten leading pharmaceutical companies are already using Cellix's technology to study drug effects on cell activity for cardiovascular, oncology, respiratory and bacteriology. To see some of our well known customers click here.